SUTRO BIOPHARMA INC shareholders Q3 2023

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.

SUTRO BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 67,754$2350.02%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 71,113$246,7620.02%
XTX Topco Ltd 20,446$70,9480.01%
ACADIAN ASSET MANAGEMENT LLC 773,867$2,6840.01%
Schonfeld Strategic Advisors LLC 355,000$1,231,8500.01%
Vontobel Holding Ltd. 450,339$1,562,6760.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 425,691$1,477,1480.01%
PANAGORA ASSET MANAGEMENT INC 369,148$1,280,9440.01%
Pentwater Capital Management LP 430,000$1,492,1000.01%
HighMark Wealth Management LLC 2,250$7,8080.01%
Baillie Gifford 1,867,654$6,480,7590.01%
Manchester Capital Management LLC 10,561$36,6470.01%
FRANKLIN RESOURCES INC 2,834,361$9,835,2320.01%
Point72 Asset Management, L.P. 533,149$1,850,0270.01%
PRELUDE CAPITAL MANAGEMENT, LLC 18,935$65,7040.00%
EXCHANGE TRADED CONCEPTS, LLC 26,764$92,8710.00%
Renaissance Technologies 302,897$1,0510.00%
Tower Research Capital LLC (TRC) 15,128$52,4940.00%
Trexquant Investment LP 20,421$70,8610.00%
MILLENNIUM MANAGEMENT LLC 1,239,251$4,300,2010.00%
External links

This page lists SUTRO BIOPHARMA INC's shareholders in Q3 2023. To view SUTRO BIOPHARMA INC's shareholder history, click here.